◆Date: September 13th, 2023
◆Time: 8:00 - 9:00 PM (CT) | 9:00-10:00 PM(ET)
◆Format: Zoom Webinar
◆Fee: Free 
※We only accept registrations with company email addresses.
※Please refrain from using a free email address or a person from a law firm.

The U.S. Supreme Court recently issued its first decision on the issue of patent enablement in nearly one hundred years.  The case at issue, Amgen v. Sanofi (decided May 18, 2023), involved a set of Amgen patents allegedly covering millions of antibodies that could each be used to reduce bad cholesterol known as “LDL.”  The Supreme Court held that the Amgen patents were invalid because they failed to comply with the enablement requirement under U.S. patent law.  Specifically, the Amgen patents only provided enough description that would enable a skilled artisan to make and use the 26 or so antibodies listed in the patent application.  Because the Amgen patents were found to be invalid, Sanofi is now free to make and sell its competing antibody product.

Part1 Panelist Introduction
 8:00-8:05 PM (CT) | 9:00-9:05 PM(ET) | 10:00-10:05 AM (JST, KST)
Part2 Lecture
 "Recent U.S. Supreme Court Amgen Case addressing the Patent Enablement Requirement"
 8:05-8:35 PM (CT) | 9:05-9:35 PM(ET) | 10:05-10:35 AM (JST, KST)
Part3 Moderated Discussion
 8:35-8:50 PM (CT) | 9:35-9:50 PM(ET) | 10:35-10:50 AM (JST, KST)
Part4 Q&A session
 8:50-9:00 PM (CT) | 9:50-10:00 PM (ET) | 10:50-11:00 AM(JST, KST)


230914_Faegre Drinker Biddle & Reath LLP_John G. Smith.png   

(Faegre Drinker Biddle & Reath LLP)
John Smith’s practice is dedicated to providing optimal results to clients in all areas of patent law. To this end, John has spent his entire career developing deep knowledge and gaining practical experience in matters involving patent litigation, post-grant proceedings, negotiations, licensing, opinions, patent prosecution and patent portfolio management. The depth and breadth of his background make him extraordinarily qualified to assess issues and risks faced by clients to help them identify and select those options with the highest likelihood of success and to implement strategies yielding the most favorable outcomes.

230914_Faegre Drinker Biddle & Reath LLP_Alison J. Baldwin.png   

(Faegre Drinker Biddle & Reath LLP)

With 20 years of experience in pharmaceutical and agricultural matters, Alison Baldwin is uniquely equipped to advance your most complex intellectual property goals. Whether you Eat it, Drink it, Wear it, Smoke it or Drive it, Alison’s extensive background in biotechnology and plant science brings a vital perspective to your project.

An experienced litigator with dozens of pharmaceutical and biotechnology cases under her belt, Alison advocates for clients in all stages of trial across a range of venues. Her experience in federal district court, the International Trade Commission, the Patent Trial and Appeal Board — along with private arbitration proceedings — informs her strategic guidance for clients in every phase of their case.

Alison is also a seasoned patent prosecutor with an emphasis on technologies and inventions relating to biology, plants and microorganisms. From patent application drafts through appeals and post-grant proceedings, she has the experience to counsel your team in the most ambitious and intricate situations.


Vlad Lobatchev
Director of Engagement Management and Data Science

As an Engagement Manager and a Director of Data Science and Strategy, Vlad Lobatchev is responsible for ensuring that our clients always receive top-tier customer experience and best-in-breed technology to enhance their e-Discovery workflows. He draws on his extensive professional experience and legal background to guide development and implementation of innovative technological solutions and workflows on client engagements. Prior to joining FRONTEO, he was an attorney for two years specializing in general corporate and finance law – taxation, contracts, corporate formation, and administration.


Shiho- square2.png

Shiho Tanaka
SVP, Discovery Consulting Division (FRONTEO USA)

Registration for this seminar has closed.

Registration for this seminar has closed.